Healthcare Sales & Marketing Network News: MB07133

Searching News Database: MB07133

HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Oct 2007
Metabasis Announces European Commission Grants Orphan Medicinal Product Designation to MB07133, Its Product Candidate for the Treatment of Primary Liver Cancer
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Sep 2007
Metabasis Announces Orphan Drug Designation Granted to MB07133, Its Product Candidate for the Treatment of Primary Liver Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 16 Apr 2007
Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
Biopharmaceuticals

HSMN NewsFeed - 5 Jan 2006
Metabasis Therapeutics, Inc. Announces Three Senior Management Additions to Development Team
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 5 additional stories matching:
MB07133
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.